Allergy Therapeuti Stock Price, News & Analysis (OTCMKTS:AGYTF)

$0.43 0.00 (0.00 %)
(As of 02/20/2018 10:32 AM ET)
Previous Close$0.43
Today's Range$0.43 - $0.43
52-Week Range$0.43 - $0.43
Volume87,000 shs
Average VolumeN/A
Market Capitalization$253.82 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Allergy Therapeuti (OTCMKTS:AGYTF)

Allergy Therapeuti logoAllergy Therapeutics plc, a specialty pharmaceutical company, focusing on allergy vaccination primarily in Europe. The company’s primary flagship products consist of the Pollinex Quattro for the treatment of allergic conditions; and monophosphoryl-lipid A, a substance that enhances the immune response to an antigen or allergen. It offers sublingual product, including Oralvac Compact; Venomil product, which is used for the wasp and bee treatment; probiotic products, such as Kallergen-Th, ATI Prob, and Pollagen; Acarovac Plus, a novel tyrosine-adsorbed, modified-allergen product developed for treatment of perennial mite allergy; and DAP, a product for use in the diagnosis of type I or immediate hypersensitivity to benzyl penicillin and related antibiotics (beta lactams) by means of cutaneous tests (prick and intradermal). It is also developing products based on synbiotics that are special formulations of prebiotics and probiotics, such as Kallergen Th and SynGut; Polyvac, a peanut VLP adjuvanted specific immunotherapy; Acarovac Plus and Acarovac MPL that are next generation products for dust mite immunotherapy; and G102, G204, G205, and G306, as well as PQBirch 301 and PQBirch 204 that are subcutaneous immunotherapies, which are in various development phases. The company markets its products in injectable and sublingual formats under various brands. Allergy Therapeutics plc was founded in 1934 and is based in Worthing, the United Kingdom.

Receive AGYTF News and Ratings via Email

Sign-up to receive the latest news and ratings for AGYTF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:AGYTF
CUSIPN/A
Phone44-19-0384-4700

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$71.98 million
Price / Sales3.53
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees440
Outstanding Shares593,440,000

Allergy Therapeuti (OTCMKTS:AGYTF) Frequently Asked Questions

What is Allergy Therapeuti's stock symbol?

Allergy Therapeuti trades on the OTCMKTS under the ticker symbol "AGYTF."

Who are some of Allergy Therapeuti's key competitors?

How do I buy Allergy Therapeuti stock?

Shares of Allergy Therapeuti can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allergy Therapeuti's stock price today?

One share of Allergy Therapeuti stock can currently be purchased for approximately $0.43.

How big of a company is Allergy Therapeuti?

Allergy Therapeuti has a market capitalization of $253.82 million and generates $71.98 million in revenue each year. Allergy Therapeuti employs 440 workers across the globe.

How can I contact Allergy Therapeuti?

Allergy Therapeuti's mailing address is Dominion Way West Sussex, Worthing X0, BN14 8SA. The company can be reached via phone at 44-19-0384-4700.


MarketBeat Community Rating for Allergy Therapeuti (AGYTF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about Allergy Therapeuti and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allergy Therapeuti (OTCMKTS:AGYTF) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Allergy Therapeuti (OTCMKTS:AGYTF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Allergy Therapeuti (OTCMKTS:AGYTF) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.02 EPS
Next Year EPS Consensus Estimate: $-0.01 EPS

Dividends

Dividend History for Allergy Therapeuti (OTCMKTS:AGYTF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Allergy Therapeuti (OTCMKTS AGYTF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Allergy Therapeuti (OTCMKTS AGYTF) News Headlines

Source:
DateHeadline
Allergy Therapeutics: Completion of recruitment in PQ Grass Phase II trialAllergy Therapeutics: Completion of recruitment in PQ Grass Phase II trial
feeds.benzinga.com - February 12 at 7:43 AM

SEC Filings

Allergy Therapeuti (OTCMKTS:AGYTF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Allergy Therapeuti (OTCMKTS AGYTF) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.